Adults with persistent acne can compare isotretinoin, a prescription drug that lowers oil production, alone versus with added fish oil. A 2026 randomized trial in 80 adults found the fish-oil combination was noninferior, meaning not worse by a preset margin, for lesion reduction and showed better moisture and triglyceride signals. The study enrolled adults ages 18-25 with moderate-to-severe acne vulgaris and gave isotretinoin 10 mg daily for 3 months. Half added 1 g fish oil daily, and half added placebo, with both patients and assessors masked to assignment.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- Who was studied and what was given?
- Did acne clear equally well?
- What about dryness and blood fats?
- How should adults use this with a dermatologist?
Who was studied and what was given?
The trial focused on young adults with persistent inflammatory acne. Entry required an Investigator Global Assessment, a clinician scale that grades overall acne severity, score of 3 or higher. That threshold selects moderate-to-severe disease rather than mild comedonal acne.
Each participant took low-dose isotretinoin every day for 3 months. The test group added 1 g fish oil, while the control group added a matching placebo. As described in the Journal of the American Academy of Dermatology abstract, the trial enrolled 40 patients per arm and tracked lesions, skin measures, and labs together the JAAD trial abstract.
Did acne clear equally well?
Total lesion counts fell in both groups over 3 months. The between-group mean difference was -6.0 lesions, with a 95% confidence interval from -16.5 to 4.5. That range met the preset noninferiority standard, so combination treatment was judged not worse than isotretinoin alone.
MIMS reporting on the JAAD trial summarized the same efficacy finding as noninferior lesion reduction with added fish oil MIMS report on the JAAD trial. For readers, the practical point is clearance, not speed: both approaches reduced counts during short-term treatment. The trial did not test whether fish oil lets patients use a lower isotretinoin dose long term.
What about dryness and blood fats?
Isotretinoin often dries skin, lips, and nasal passages and can raise blood fats. This trial measured skin hydration with a corneometer, a probe that estimates water in the outer skin, plus mucocutaneous effects, triglycerides, and liver enzymes. The fish-oil group had smaller drops in skin hydration than placebo, suggesting better moisture preservation.
The group also had smaller rises in serum triglycerides, suggesting less lipid elevation. The U.S. National Library of Medicine PubMed abstract reports both tolerability signals from the same trial the PubMed abstract of the trial.
- Compare clearance: total lesion change over 3 months
- Compare comfort: skin hydration and mouth, nose, and lip dryness
- Compare labs: triglycerides and liver transaminases, enzymes that signal liver stress
How should adults use this with a dermatologist?
Three months is short for acne decisions. The authors noted that IGA-based entry may have affected the noninferiority analysis, and the brief duration limits conclusions about lasting clearance, relapse, or cumulative toxicity. Adults should treat the result as early tolerability evidence, not proof of long-term equivalence.
For context, the American Academy of Dermatology 2024 acne guidelines strongly recommend oral isotretinoin for severe acne, acne causing scarring or psychosocial burden, or acne that failed standard oral or topical therapy, usually within combination care. A JAMA Dermatology consensus advises checking ALT, a liver enzyme, and triglycerides within a month before starting isotretinoin and again at peak dose. Bring baseline ALT and triglyceride results and a list of current dryness symptoms to that visit.
You Might Also Like
- Topical Acne Antibiotics and Resistance After the 2026 Meta-Analysis: How Adults With Persistent Acne Can Compare Treatment Options
- Concurrent Acne Procedures and Isotretinoin in 2026 Research: Safety and Monitoring Questions for Adults With Persistent Acne
- Omega-3 Balance and Acne Questions in the 2026 Diet Review: What the Review Supports and Does Not Prove for Adults With Persistent Acne